Molecular insights from bariatric surgery

Reviews in Endocrine and Metabolic Disorders

Volumn 12, Issue 3, 2011, Pages 211-217

  Kohli, Rohit ^a   Stefater, Margaret A ^a   Inge, Thomas H ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Bariatric surgery; Bile acids; Diabetes; Molecular mechanisms; Obesity; Steatohepatitis

Indexed keywords

ADIPONECTIN; GLUCAGON LIKE PEPTIDE 1; LEPTIN; RESISTIN;

ARTICLE; BARIATRIC SURGERY; CARDIOVASCULAR DISEASE; CHOLECYSTITIS; CHOLELITHIASIS; COMORBIDITY; ENERGY EXPENDITURE; GASTRECTOMY; GASTRIC BANDING; GLUCOSE INTOLERANCE; HUMAN; HYPERLIPIDEMIA; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; QUALITY OF LIFE; WEIGHT REDUCTION;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; FATTY LIVER; HUMANS; OBESITY; WEIGHT LOSS;

EID: 80054864818     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-011-9172-6     Document Type: Article

References (63)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. Jama 303: 235-41
2. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. Jama 303: 242-9
3. Brolin RE. Update: NIH consensus conference. Gastrointestinal surgery for severe obesity. Nutrition. 1996;12:403-4. (Pubitemid 26295077)
4. Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. Jama. 2003;289:1813-9. (Pubitemid 37430251)
5. De Maria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356:2176-83. (Pubitemid 47010843)
6. Inge TH, Miyano G, Bean J, Helmrath M, Courcoulas A, Harmon CM, et al. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics. 2009;123:214-22.
7. Xanthakos SA, Inge TH. Nutritional consequences of bariatric surgery. Curr Opin Clin Nutr Metab Care. 2006;9:489-96. (Pubitemid 44097823)
8. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. Jama. 2004;292:1724-37. (Pubitemid 39346675)
9. Cummings DE, Overduin J, Foster-Schubert KE, Carlson MJ. Role of the bypassed proximal intestine in the anti-diabetic effects ofbariatric surgery. Surg Obes Relat Dis. 2007;3:109-15. (Pubitemid 46444709)
10. Peterli R, Wolnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg. 2009;250:234-41.
11. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(248-256):e5.
12. Fetner R, Mc Ginty J, Russell C, Pi-Sunyer FX, Laferrere B. Incretins, diabetes, and bariatric surgery: a review. Surg Obes Relat Dis. 2005;1:589-97. discussion 597-8.
13. Cota D, Proulx K, Seeley RJ. The role of CNS fuelsensingin energy and glucosere gulation. Gastroenterology. 2007;132:2158-68. (Pubitemid 46693748)
14. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15:914-20.
15. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med. 2009;15:921-9.
16. Lumeng CN, Maillard I, Saltiel AR. T-ing up inflammation in fat Nat Med. 2009;15:846-7.
17. Verdich C, Toubro S, Buemann B, Lysgard Madsen J, Juul Holst J, Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int J Obes Relat Metab Disord. 2001;25:1206-14. (Pubitemid 32721544)
18. Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005;90:359-65. (Pubitemid 40116682)
19. Murri M, Garcia-Fuentes E, Garcia-Almeida JM, Garrido-Sanchez L, Mayas MD, Bernal R, et al. Changes in oxidative stress and insulin resistance in morbidly obese patients after bariatric surgery. Obes Surg. 2010;20:363-8.
20. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblas-tosis after gastric-bypass surgery. N Engl J Med. 2005;353:249-54. (Pubitemid 41058324)
21. Meier JJ, Butler AE, Galasso R, Butler PC Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diab Care. 2006;29:1554-9. (Pubitemid 44127580)
22. Zhang Y Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-32. (Pubitemid 24365442)
23. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, et al. Effects ofrecombinant leptin therapy in a child with congenital leptin deficiency N Engl J Med. 1999;341:879-84. (Pubitemid 29427050)
24. Seeley RJ, van Dijk G, Campfield LA, Smith FJ, Burn P, Nelligan JA, et al. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm Metab Res. 1996;28:664-8. (Pubitemid 27057912)
25. Garcia de la Torre N, Rubio MA, Bordiu E, Cabrerizo L, Aparicio E, Hernandez C, et al. Effects ofweight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab. 2008;93:4276-81. (Pubitemid 352789522)
26. Trakhtenbroit MA, Leichman JG, Algahim MF, Miller 3rd CC, Moody FG, Lux TR, et al. Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery. Am J Med. 2009;122:435-42.
27. Whitson BA, Leslie DB, Kellogg TA, Maddaus MA, Buchwald H, Billington CJ, et al. Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a prelimi-nary study. J Surg Res. 2007;142:295-300. (Pubitemid 47418830)
28. Guijarro A, Osei-Hyiaman D, Harvey-White J, Kunos G, Suzuki S, Nadtochiy S, et al. Sustained weight loss after Roux-en-Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function. Ann Surg. 2008;247:779-90. (Pubitemid 351591513)
29. Kotidis EV, Koliakos G, Papavramidis TS, Papavramidis ST The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weight-reducing effect of this procedure? Obes Surg. 2006;16:554-9. (Pubitemid 43786076)
30. Korner J, Inabnet W, Febres G, Conwell IM, Mc Mahon DJ, Salas R, et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond). 2009;33:786-95.
31. Holdstock C, Engstrom BE, Ohrvall M, Lind L, Sundbom M, Karlsson FA. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab. 2003;88:3177-83. (Pubitemid 36877491)
32. Dunn JP, Cowan RL, Volkow ND, Feurer ID, Li R, Williams DB, et al. Decreased dopamine type 2 receptor availability afterbariatric surgery: preliminary findings. Brain Res. 2010;1350:123-30.
33. Stoeckli R, Chanda R, Langer I, Keller U. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res. 2004;12:346-50. (Pubitemid 41132559)
34. Nijhuis J, van Dielen FM, Buurman WA, Greve JW. Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study. Obes Surg. 2004;14:783-7. (Pubitemid 38982263)
35. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316:129-39.
36. Woods SC, DAlessio DA. Central control of body weight and appetite. J Clin Endocrinol Metab. 2008;93:S37-50.
37. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 2002;418:650-4.
38. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247:401-7.
39. Gallwitz B, Ropeter T, Morys-Wortmann C, Mentlein R, Siegel EG, Schmidt WE. GLP-1-analogues resistant to degradation by dipeptidyl-peptidase IV in vitro. Regul Pept. 2000;86:103-11. (Pubitemid 30003967)
40. Laferrere B. Effect ofgastric bypass surgery on the incretins. Diab Metab. 2009;35:513-7.
41. Sautin YY, Crawford JM, Svetlov SI. Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line. Am J Physiol Cell Physiol. 2001;281:C2010-9.
42. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-30. (Pubitemid 34755670)
43. Mingrone G, Granato L, Valera-Mora E, Iaconelli A, Calvani MF, Bracaglia R, et al. Ultradian ghrelin pulsatility is disrupted in morbidly obese subjects after weight loss induced by malabsorp-tive bariatric surgery. Am J Clin Nutr. 2006;83:1017-24. (Pubitemid 44713099)
44. Williams DL, Grill HJ, Cummings DE, Kaplan JM. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology. 2003;144:5184-7. (Pubitemid 37476045)
45. Kirchner H, Gutierrez JA, Solenberg PJ, Pfluger PT, Czyzyk TA, Willency JA, et al. GOAT links dietary lipids with the endocrine control ofenergy balance. Nat Med. 2009;15:741-5.
46. Patti ME, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ, Badman MK, Maratos-Flier E, Mun EC, Pihlajamaki J, Auwerx J, Goldfine AB. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring). (2009)
47. Pellicciari R, Gioiello A, Macchiarulo A, Thomas C, Rosatelli E, Natalini B, et al. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity. J Med Chem. 2009;52:7958-61.
48. Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, et al. TGR5-mediated bile acid sensing controls glucose homeosta-sis. Cell Metab. 2009;10:167-77.
49. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439:484-9. (Pubitemid 43152840)
50. Nakatani H, Kasama K, Oshiro T, Watanabe M, Hirose H, Itoh H. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism. 2009;58:1400-7.
51. Woods SC, Schwartz MW, Baskin DG, Seeley RJ. Food intake and the regulation ofbody weight. Annu Rev Psychol. 2000;51:255-77.
52. Stefater MA, Perez-Tilve D, Chambers AP, Wilson-Perez HE, Sandoval DA, Berger J, et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology. 2010;138:2426-36. 2436 e1-3.
53. Sandoval D, Cota D, Seeley RJ. The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu Rev Physiol. 2008;70:513-35. (Pubitemid 351738190)
54. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37:649-61. (Pubitemid 36262986)
55. Strader AD, Clausen TR, Goodin SZ, Wendt D. Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats. Obes Surg. 2009;19:96-104.
56. Epstein LH, Paluch R, Coleman KJ. Differences in salivation to repeated food cues in obese and nonobese women. Psychosom Med. 1996;58:160-4. (Pubitemid 26097168)
57. Halmi KA, Mason E, Falk JR, Stunkard A. Appetitive behavior after gastric bypass for obesity. Int J Obes. 1981;5:457-64. (Pubitemid 11014632)
58. Brown EK, Settle EA, Van Rij AM. Food intake patterns of gastric bypass patients. J Am Diet Assoc. 1982;80:437-43.
59. Belle SH, Berk PD, Courcoulas AP, Flum DR, Miles CW, Mitchell JE, et al. Safety and efficacy of bariatric surgery: longitudinal assessment ofbariatric surgery. Surg Obes Relat Dis. 2007;3:116-26. (Pubitemid 46444704)
60. Inge TH, Jenkins TM, Zeller M, Dolan L, Daniels SR, Garcia VF, et al. Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass. J Pediatr. 2010;156(103-108):e1.
61. Kohli R, Kirby M, Setchell KD, Jha P, Klustaitis K, Woollett LA, Pfluger PT, Balistreri WF, Tso P, Jandacek RJ, Woods SC, Heubi JE, Tschoep MH, DAlessio DA, Shroyer NF, Seeley RJ. Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity related co-morbidities. Am J Physiol Gastrointest Liver Physiol. (2010)
62. Johnson KM. Dutogliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus. Curr Opin Investig Drugs. 2010;11:455-63.
63. Deacon CF, Holst JJ. Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes. Expert Opin Investig Drugs. 2010;19:133-40.